✦ LIBER ✦

Clinical perspectives for irreversible tyrosine kinase inhibitors in cancer

✍ Scribed by Caterina Carmi; Marco Mor; Pier Giorgio Petronini; Roberta R. Alfieri

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tyrosine kinase inhibitors: A clinical p

✍ Sanjay Goel; Sridhar Mani; Roman Perez-Soler 📂 Article 📅 2002 🏛 Current Science Inc. 🌐 English ⚖ 579 KB

Hepatotoxicity of Tyrosine Kinase Inhibi

✍ Shah, Rashmi R.; Morganroth, Joel; Shah, Devron R. 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 322 KB

Discovery of Selective Irreversible Inhi

✍ Zhengying Pan; Heleen Scheerens; Shyr-Jiann Li; Brian E. Schultz; Paul A. Spreng 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 242 KB

Clinical Development of Src Tyrosine Kin

✍ David Lee Lee; Oliver Gautschi 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 292 KB

Tyrosine Kinase Inhibitors in Lung Cance

✍ Thomas, Anish; Rajan, Arun; Giaccone, Giuseppe 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Tyrosine kinase inhibitors in cancer the

✍ Srinivasan Madhusudan; Trivadi S. Ganesan 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 518 KB